DJ Sarepta Therapeutics Is Maintained at Outperform by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/SRPT/ratings
(END) Dow Jones Newswires
March 02, 2021 07:19 ET (12:19 GMT)
DJ Sarepta Therapeutics Price Target Raised to $126.00/Share From $125.00 by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/SRPT/ratings
(END) Dow Jones Newswires
March 02, 2021 07:19 ET (12:19 GMT)